Impaired immune responsiveness in the presence of malignant disease poses the question of whether malignancy preferentially develops in individuals with impaired immunity. Virus-induced mouse leukemia is a useful model for answering this question, because one is dealing with a population in which the ultimate development of malignancy can be predicted. Several studies have been made in animals with the rapidly developing leukemias that follow the injection of Friend or Rauscher virus (3, 11, 18, 19, 22, 23) . These diseases become overt only a few weeks after inoculation of the virus (2, 15) . Immunological reactivity has been assessed by measuring humoral antibody titers, which have been shown to be depressed from shortly after virus inoculation to a stage of advanced disease. The short latent period between the inoculation of the virus and the appearance of overt malignant changes makes it difficult to evaluate true preleukemic immune responses in studies of these leukemias.
In lymphomas induced by the Moloney or Gross virus, the latent period from inoculation of the virus to the development of overt disease is several months. During much of this time, the morphology of the lymphoid tissues remains normal (9, 10) . The infected animals ultimately show a high incidence of lymphoma, originating in the thymus and disseminating to lymphoid and other tissues (14) . These diseases lend themselves to the study of immune response in a period when the animal is essentially normal, but destined to de-velop lymphoma. Cellular immunity has been shown to be depressed by measurement of skingraft survival in Gross virus-infected preleukemic C3H mice (7) and in Gross virus-carrying preleukemic AKR mice (8) . No serial studies have been done to follow the extent of impairment of cellular immunity at different times in the preleukemic period. Some controversy exists with regard to the impairment of humoral immunity in preleukemic Moloney and Gross virus-infected animals: some studies show depression of antibody formation before the appearance of overt lymphoma (4, 5, 21) , whereas others deny an impairment of humoral immune response during the induction phase of this disease (16, 22) .
In the present investigation, humoral and cellular immunity as well as immunoglobulins were studied in preleukemic, Gross virus-infected C3H/HeJ mice and in AKR mice, presumably congenitally infected with virus, at intervals during the prelymphoma period, to determine the extent and time of development of changes in the immune responsiveness of these animals.
MATERIALS AND METHODS Animals. Two groups of mice from the inbred colonies maintained in this laboratory were used-the AKR strain, which naturally harbors Gross leukemogenic virus, transmits it to its progeny, and dies from lymphoma usually between the ages of 6 and 12 months; and the C3H/HeJ strain, which does not IMMUNE RESPONSE IN PRELEUKEMIC MICE lymphoma between the ages of 3 and 9 months when injected with Gross virus as newborns.
Mice were assigned to experiments in groups at the time of birth. Animals dying before the time of the experiment were autopsied to determine the cause of death. The thymus, lymph nodes, and spleen were examined. The diagnosis of lymphoma was made if a characteristic massive enlargement of the thymus was present. This was often accompanied by enlargement of the spleen, lymph nodes, and liver. This enlargement is caused by an infiltration of cells with the microscopic morphology of a lymphoblastic lymphoma. The words lymphoma and leukemia in this paper are used interchangeably to describe this disease.
Virus. The virus originally was supplied by L. Gross in the form of a leukemic C3Hf/Bi mouse and has been maintained in this laboratory by repeated passage into 3-to 5-day-old AKR mice in which it produces a 100% incidence of accelerated lymphoma.
Cell-free filtrates were made from leukemic tissues of AKR mice with accelerated lymphoma according to a procedure detailed previously (26 (6) . Groups of mice were injected into the four footpads (0.05 ml in each foot) and the neck muscles (0.1 ml) with complete Freund's adjuvant 3 weeks prior to being studied for cellular immunity. At the time of the experiment, the animals were anesthetized and killed by bleeding from the axillary artery. By washing the peritoneal cavity several times with small amounts ofcold saline through a small incision in the abdominal wall, peritoneal cell suspensions were obtained, containing 3 X 106 to 9 X 106 cells in 12 to 15 ml of saline, of which 60 to 90% were macrophages and 10 to 40% were lymphocytes. Lymph node cell suspensions were prepared from the same animals by grinding axillary and inguinal lymph nodes in a tissue grinder with cold saline, and 0.2 to 0.5 ml of this lymph node cell suspension containing 2 X 106 to 5 X 106 cells was added to the peritoneal cell suspension. The cell mixture was then centrifuged at 900 rev/min for 6 min; the supematant was removed, and the cells were washed twice with cold Eagle's minimal essential medium. After the second washing, the cells were suspended in a small amount of the medium and placed into two to four capillary tubes 0.7 mm in inner diameter and 75 mm long. These tubes were sealed with plastic clay, and the cells were sedimented by centrifugation. The tubes were then cut at the cell-fluid interphase, and the cell-containing ends were placed into two Sykes-Moore culture chambers, one of which was filled with 15 ,ug of PPD (tuberculin, purified protein derivative) in Eagle's medium; the other was filled with Eagle's medium only, to serve as a control. The prepared chambers were incubated for 18 to 24 hr at 37 C. At that time, macrophage migration was observed under a dissecting microscope, the samples were photographed, and two diameters of the migration area, which had the shape of an elipse, were measured on black and white enlargements (X 35). The results are expressed as the percentage of migration area (obtained by multiplying the two diameters) in the antigen-containing chamber, based on the full migration area in the uninhibited control chamber as 100%.
RESULTS
Mortality from leukemia. Data from 168 AKR mice showed that the majority of the animals die with lymphoma between the ages of 7 and 11 months, and that by the age of 18 months 100% of these animals are dead from lymphoma. Mortality from lymphoma of C3H/HeJ mice was calculated for the 206 experimental animals used in this study. Between the ages of 3 and 10 months, about 50% of virus-injected C3H mice died from leukemia. These data compare very well with previous results obtained in this laboratory (26 mice showed no significant or consistent differences. However, in AKR mice the protein and gamma globulin levels appeared to be somewhat lower than in C3H/HeJ mice. This most likely was due to the difference in strain and may not be related to the presence of virus. Low Gamma globulin levels were found in 12-month-old AKR mice with lymphoma.
Hemagglutinin and hemolysin titers. In Fig. 1 , the mean values for hemagglutinin and hemolysin titers of AKR mice and virus-injected and normal C3H mice are presented. No specific alteration in the immune response to SRBC could be demonstrated in animals with natural or induced viral infection. At 12 months, reduced titers were found in two AKR mice with generalized lymphoma, and one mouse with lymphoma had a normal immune response.
MMI. The results of the study of cellular immune response as assessed with the MMI test are represented in Fig. 2 and 3 . The inhibition of macrophage migration is due to the production of MMI factor by immunologically stimulated lymphocytes (1). This is a qualitative rather than a quantitative method, which is dependent on the reactivity of a given animal to a specific antigen. The normal range of the results appeared to be quite wide, and individual animals were not necessarily representative of a whole group. The scattergram in Fig. 2 demonstrates the wide range of values found. However, when mean values were compared (Fig. 3) , it was clear that macrophage migration was inhibited in immunnized, normal C3H/HeJ mice in the presence of antigen throughout life to an average level of 60%. Such inhibition could not be demonstrated in preleukemic AKR mice or in C3H/HeJ mice given neonatal inoculation of the Gross leukemogenic virus. In these animals, macrophage migration was similar to that found in the unimmunized controls of the same experimental group. This difference between normal and preleukemic mice persisted throughout the observation period from the age of 1.5 to 10 or 12 months. This difference in MMI between normal animals and those with naturally occurring or induced virus infection for most points was highly significant as calculated with the Student t test (Table 2) . (4, 5) . Peterson and co-workers, using a Gross virus-infected C3H strain, also showed some impairment of antibody production against T2 phage (21) . On the other hand, Salaman and Wedderburn did not find defective production of hemagglutinins in Moloney virusinfected preleukemic Balb/c mice (22) . Metcalf and Moulds, in a similar study of humoral immunity in preleukemic AKR mice, reported normal formation of the hemolytic plaques by spleen cells and normal hemagglutinin or hemolysin titers after stimulation of these animals with SRBC, unless obvious lymphoma was present (16) .
In the present report, the MMI test when adapted to mice demonstrated that the MMI factor is depressed in the prelymphoma period in animals with both virus-induced and spontaneous disease. If, as has been shown by others (6, 12, 24, 25) , MMI is a true correlate of delayed hypersensitivity or, in other terms, cellular immunity, these results agree with published studies (7, 8) showing impaired cellular immune response in preleukemic C3H and AKR mice as assessed by prolonged skin allograft survival.
The finding of an impaired cellular immune response but intact humoral immunity in the mice used in the present studies should not be unexpected. The thymus has been shown to be necessary for the development of normal cellular immunity (17) , and this same organ is the target for the development of lymphoma in the two host systems studied. This fact allows for speculation as to the mechanisms of lymphomagenesis. It could be postulated that impaired cellular immunity is the result of a viral attack on thymus cells. This might then cause a derangement of thymus function which, occurring over a period of time, could ultimately result in lymphoma. Alternatively, the fact that impaired cellular immunity occurs long before overt lymphoma suggests a dual role for the virus: immunosuppression and malignant transformation. Tumor-specific antigens have been demonstrated in Gross virusinduced lymphomas (20) ; therefore, lymphoma could result when the virus-transformed malignant cell found itself in an environment of impaired host cellular immunity. The present studies do not provide sufficient evidence to allow conclusions along these lines, but they do show that specific functional changes in the immune mechanism occur in the prelymphoma period that must be related to the organ in which the malignant disease is ultimately found.
